| RS2514423508 |
ITPA
|
Health Risk |
Likely pathogenic |
Inosine triphosphatase deficiency, Inosine triphosphatase deficiency |
| RS2514423602 |
ITPA
|
Health Risk |
Pathogenic |
Inosine triphosphatase deficiency, Inosine triphosphatase deficiency |
| RS2514423744 |
ITPA
|
Health Risk |
Pathogenic |
Inosine triphosphatase deficiency, Inosine triphosphatase deficiency |
| RS2514425248 |
ITPA
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 35 |
| RS2514425313 |
ITPA
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 35 |
| RS2514426253 |
BMP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Short stature, facial dysmorphism |
| RS2514426566 |
BMP2
|
Health Risk |
Pathogenic |
Type A2 brachydactyly, Short stature |
| RS2514426680 |
BMP2
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2514426884 |
BMP2
|
Health Risk |
Pathogenic |
— |
| RS2514427047 |
BMP2
|
Health Risk |
Pathogenic |
Dextro-looped transposition of the great arteries, Dextro-looped transposition of the great arteries |
| RS2514427081 |
BMP2
|
Health Risk |
Pathogenic |
Ventricular septal defect 1, Ventricular septal defect 1 |
| RS2514427113 |
BMP2
|
Health Risk |
Likely pathogenic |
BMP2-related disorder, BMP2-related disorder |
| RS2514427148 |
BMP2
|
Health Risk |
Pathogenic |
Atrial septal defect 1, Atrial septal defect 1 |
| RS2514428654 |
MCM8
|
Health Risk |
Likely pathogenic |
— |
| RS2514432160 |
RYR1
|
Health Risk |
Likely pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514433288 |
RYR1
|
Health Risk |
Likely pathogenic |
— |
| RS2514433461 |
RYR1
|
Health Risk |
Pathogenic |
— |
| RS2514436908 |
CNOT3
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with speech delay, autism |
| RS2514437642 |
ITPA
|
Health Risk |
Pathogenic |
Inosine triphosphatase deficiency, Inosine triphosphatase deficiency |
| RS2514443324 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514443505 |
MYH14
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2514444674 |
RYR1
|
Health Risk |
Likely pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514447074 |
PLEKHG2
|
Health Risk |
Likely pathogenic |
Leukodystrophy and acquired microcephaly with or without dystonia, Leukodystrophy and acquired microcephaly with or without dystonia |
| RS2514448687 |
SMARCA4
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2514451510 |
SMARCA4
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2514452515 |
NLRP5
|
Health Risk |
Pathogenic |
Oocyte/zygote/embryo maturation arrest 19, Oocyte/zygote/embryo maturation arrest 19 |
| RS2514452594 |
SMARCA4
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2514452737 |
NLRP5
|
Health Risk |
Conflicting classifications of pathogenicity |
Oocyte/zygote/embryo maturation arrest 19, Oocyte/zygote/embryo maturation arrest 19 |
| RS2514458622 |
ITPA
|
Health Risk |
Likely pathogenic |
Inosine triphosphatase deficiency, Inosine triphosphatase deficiency |
| RS2514460185 |
ITPA
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Inosine triphosphatase deficiency |
| RS2514462373 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514462770 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514464325 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia, susceptibility to |
| RS2514466071 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2514467771 |
LIPE
|
Health Risk |
Pathogenic |
LIPE-related familial partial lipodystrophy, LIPE-related familial partial lipodystrophy |
| RS2514477320 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514477591 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514477883 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS2514485342 |
RYR1
|
Health Risk |
Likely pathogenic |
— |
| RS2514485464 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514485599 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514485704 |
RYR1
|
Health Risk |
Likely pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514485712 |
RYR1
|
Health Risk |
Likely pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514486401 |
MKKS
|
Health Risk |
Likely pathogenic |
McKusick-Kaufman syndrome, McKusick-Kaufman syndrome |
| RS2514486688 |
MKKS
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 6, Bardet-Biedl syndrome 6 |
| RS2514486985 |
MKKS
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 6, Bardet-Biedl syndrome 6 |
| RS2514486998 |
MKKS
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 6, Bardet-Biedl syndrome 6 |
| RS2514487000 |
MKKS
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, McKusick-Kaufman syndrome |
| RS2514487125 |
MKKS
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 6, Bardet-Biedl syndrome 6 |
| RS2514489025 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS2514489090 |
MKKS
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 6, Bardet-Biedl syndrome 6 |
| RS2514489097 |
MKKS
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, McKusick-Kaufman syndrome |
| RS2514489594 |
ITPA
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 35 |
| RS2514490284 |
MKKS
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, McKusick-Kaufman syndrome |
| RS2514490293 |
MKKS
|
Health Risk |
Pathogenic/Likely pathogenic |
MKKS-related disorder, Bardet-Biedl syndrome |
| RS2514490367 |
MKKS
|
Health Risk |
Pathogenic |
McKusick-Kaufman syndrome, Bardet-Biedl syndrome |
| RS2514490385 |
MKKS
|
Health Risk |
Likely pathogenic |
MKKS-related disorder, MKKS-related disorder |
| RS2514494395 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related myopathy, RYR1-related myopathy |
| RS2514495299 |
MED25
|
Health Risk |
Likely pathogenic |
Congenital cataract-microcephaly-nevus flammeus simplex-severe intellectual disability syndrome, Congenital cataract-microcephaly-nevus flammeus simplex-severe intellectual disability syndrome |
| RS2514495501 |
MKKS
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 6, Bardet-Biedl syndrome 6 |
| RS2514495504 |
MKKS
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, McKusick-Kaufman syndrome |
| RS2514495508 |
MKKS
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 6, Bardet-Biedl syndrome 6 |
| RS2514495642 |
MKKS
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 6, Bardet-Biedl syndrome 6 |
| RS2514495654 |
MKKS
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 6, Bardet-Biedl syndrome 6 |
| RS2514496005 |
MKKS
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome 6, Bardet-Biedl syndrome |
| RS2514496343 |
MKKS
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 6, Bardet-Biedl syndrome 6 |
| RS2514496360 |
MKKS
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 6, Bardet-Biedl syndrome 6 |
| RS2514496791 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia, susceptibility to |
| RS2514496958 |
MKKS
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 6, Bardet-Biedl syndrome 6 |
| RS2514497007 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS2514497043 |
MKKS
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, McKusick-Kaufman syndrome |
| RS2514497096 |
MKKS
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 6, McKusick-Kaufman syndrome |
| RS2514497218 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514497482 |
MKKS
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 6, Bardet-Biedl syndrome 6 |
| RS2514497550 |
MKKS
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome 6, Bardet-Biedl syndrome |
| RS2514497554 |
MKKS
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, McKusick-Kaufman syndrome |
| RS2514497703 |
MKKS
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 6, Bardet-Biedl syndrome 6 |
| RS2514498287 |
MKKS
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 6, Bardet-Biedl syndrome 6 |
| RS2514498304 |
MKKS
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, McKusick-Kaufman syndrome |
| RS2514498517 |
MKKS
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, McKusick-Kaufman syndrome |
| RS2514500246 |
MCM8
|
Health Risk |
Likely pathogenic |
— |
| RS2514500387 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS2514503723 |
SLC4A11
|
Health Risk |
Likely pathogenic |
Congenital hereditary endothelial dystrophy of cornea, Congenital hereditary endothelial dystrophy of cornea |
| RS2514506380 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2514506387 |
JAG1
|
Health Risk |
Likely pathogenic |
Hepatoblastoma, Hepatoblastoma |
| RS2514507703 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2514507734 |
JAG1
|
Health Risk |
Likely pathogenic |
JAG1-related disorder, JAG1-related disorder |
| RS2514507762 |
JAG1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2514507811 |
JAG1
|
Health Risk |
Likely pathogenic |
JAG1-related disorder, JAG1-related disorder |
| RS2514507971 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2514508256 |
JAG1
|
Health Risk |
Likely pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2514508344 |
JAG1
|
Health Risk |
Pathogenic/Likely pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2514508349 |
JAG1
|
Health Risk |
Likely pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2514508367 |
JAG1
|
Health Risk |
Pathogenic/Likely pathogenic |
Alagille syndrome due to a JAG1 point mutation, JAG1-related disorder |
| RS2514508523 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2514509209 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2514509349 |
JAG1
|
Health Risk |
Pathogenic |
JAG1-related disorder, JAG1-related disorder |
| RS2514509368 |
JAG1
|
Health Risk |
Likely pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2514509543 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS2514509570 |
JAG1
|
Health Risk |
Likely pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |